All ACE2 articles
-
NewsCertain nasal bacteria may boost the risk for COVID-19 infection, study finds
Certain types of nasal bacteria can affect the levels of key proteins the Covid-19 virus needs to enter human cells, offering new insight into why some people are more vulnerable to the disease than others.
-
NewsGenetic mutation linked to higher SARS-CoV-2 risk
Researchers have identified a novel genetic risk factor for SARS-CoV-2 infection, providing new insights into the virus’ ability to invade human cells.
-
NewsZoonotic transmission of Covid has led to infections in more than 30 mammalian species
Zoonotic transmission of severe acute respiratory coronavirus 2 (SARS-CoV-2) has been found to result in infections in more than 30 mammalian species, according to a study published in Zoonoses journal.
-
NewsVaping can increase susceptibility to infection by SARS-CoV-2
Vapers are susceptible to infection by SARS-CoV-2, the virus that spreads COVID-19 and continues to infect people around the world, a new study has found.
-
NewsScientists make COVID receptor protein in mouse cells
Initially motivated to make receptor-based sensors and therapies for COVID-19, scientists develop general strategy for producing other complex proteins.
-
NewsLong-acting biologic has transmucosal transport properties that arrest Covid variants
Scientists report on a tailored ACE2 biologic, where ACE2 is fused to an engineered human albumin variant.
-
NewsStudy shows engineered gut bacteria can treat hypertension
Scientists have proven that engineered bacteria can lower blood pressure, a finding that opens new doors in the pursuit of harnessing our body’s own microbiome to treat hypertension.
-
NewsMonitoring bats can help ID coronaviruses with pathogen potential
Researchers who found novel coronaviruses in UK bats say genetic surveys of the viruses should be regularly conducted, even if none of those viruses can infect humans yet.
-
NewsHighly infective Covid virus needs only a single door opener
Researchers have provided evidence that a single virus binds to a single receptor, opening the door for a highly efficient infection.